FMI
BNTX icon

F/M Investments’s BioNTech BNTX Stock Holding History

F/M Investments’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,313
Closed -$296K – 44
2022
Q2 		$296K Buy
+1,313
New +$201K 0.23% 49
2021
Q4 		– Sell
-1,341
Closed -$366K – 82
2021
Q3 		$366K Buy
1,341
+28
+2% +$8.9K 0.26% 57
2021
Q2 		$296K Buy
+1,313
New +$248K 0.23% 49

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

F/M Investments's BNTX Position: Q3 2022 in Review

F/M Investments sold out of BioNTech (BNTX) in Q3 2022, closing a stake of 1,313 shares — an estimated $296K sold.

F/M Investments first reported a position in BNTX in Q2 2021 and held it in 3 quarters. The position peaked at $366K in Q3 2021. 264 funds tracked by Wall St. Rank hold BNTX as of Q3 2022.

  • F/M Investments reported no remaining BioNTech position as of Q3 2022 after selling out during the quarter.
  • F/M Investments sold 1,313 BioNTech shares in Q3 2022, an estimated $296K.
  • F/M Investments first reported a position in BioNTech in Q2 2021 and held it in 3 quarters.
  • F/M Investments's BioNTech position peaked at $366K in Q3 2021.
  • 264 funds tracked by Wall St. Rank held BioNTech as of Q3 2022.

Based on F/M Investments's 13F filing for Q3 2022, filed 4 Nov 2022.